https://www.selleckchem.com/products/h-151.html
Interstitial lung disease is frequent in systemic sclerosis (SSc-ILD) and associates with significantly reduced quality of life. Here we aimed to analyse patient pathways, and experiences of patients and healthcare providers (HCPs) in order to identify unmet needs in the management of SSc-ILD patients. Semi-structured qualitative interviews conducted in eight European countries looked at HCP (n=95) and patient perspective (n=47), using two sets of 70 research questions. Pre-diagnostic, diagnostic and post-diagnostic phases of the patient
Like
Comment
Share
